Biohaven Pharmaceutical Holding Stock Price History

BHVN Stock  USD 29.87  1.17  3.77%   
If you're considering investing in Biohaven Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biohaven Pharmaceutical stands at 29.87, as last reported on the 25th of March, with the highest price reaching 31.18 and the lowest price hitting 29.65 during the day. Biohaven Pharmaceutical secures Sharpe Ratio (or Efficiency) of -0.0648, which signifies that the company had a -0.0648 % return per unit of risk over the last 3 months. Biohaven Pharmaceutical Holding exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biohaven Pharmaceutical's Mean Deviation of 2.8, standard deviation of 3.92, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide.
  
Biohaven Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0648

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBHVN

Estimated Market Risk

 3.92
  actual daily
35
65% of assets are more volatile

Expected Return

 -0.25
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.06
  actual daily
0
Most of other assets perform better
Based on monthly moving average Biohaven Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biohaven Pharmaceutical by adding Biohaven Pharmaceutical to a well-diversified portfolio.

Biohaven Pharmaceutical Stock Price History Chart

There are several ways to analyze Biohaven Stock price data. The simplest method is using a basic Biohaven candlestick price chart, which shows Biohaven Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 11, 202542.53
Lowest PriceMarch 10, 202527.63

Biohaven Pharmaceutical March 25, 2025 Stock Price Synopsis

Various analyses of Biohaven Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Biohaven Stock. It can be used to describe the percentage change in the price of Biohaven Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Biohaven Stock.
Biohaven Pharmaceutical Price Action Indicator(1.13)
Biohaven Pharmaceutical Price Daily Balance Of Power(0.76)
Biohaven Pharmaceutical Price Rate Of Daily Change 0.96 
Biohaven Pharmaceutical Accumulation Distribution 43,901 

Biohaven Pharmaceutical March 25, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Biohaven Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Biohaven Pharmaceutical intraday prices and daily technical indicators to check the level of noise trading in Biohaven Stock and then apply it to test your longer-term investment strategies against Biohaven.

Biohaven Stock Price History Data

The price series of Biohaven Pharmaceutical for the period between Wed, Dec 25, 2024 and Tue, Mar 25, 2025 has a statistical range of 14.9 with a coefficient of variation of 11.99. The prices are distributed with arithmetic mean of 35.89. The median price for the last 90 days is 37.28.
OpenHighLowCloseVolume
03/25/2025 30.89  31.18  29.65  29.87  894,668 
03/24/2025 28.99  31.08  28.78  31.04  1,071,400 
03/21/2025 27.76  28.88  27.21  28.54  1,093,289 
03/20/2025 28.25  28.75  27.91  28.18  832,685 
03/19/2025 28.73  29.26  28.30  28.75  577,362 
03/18/2025 29.38  29.61  28.66  28.85  510,403 
03/17/2025 29.13  29.83  28.38  29.66  738,542 
03/14/2025 28.76  29.65  28.50  29.15  653,840 
03/13/2025 29.25  29.73  27.94  28.22  717,679 
03/12/2025 29.92  30.35  28.90  29.41  922,875 
03/11/2025 27.40  29.62  26.96  29.41  1,991,611 
03/10/2025 28.62  29.47  27.40  27.63  1,903,997 
03/07/2025 30.40  31.08  29.61  29.86  1,165,012 
03/06/2025 29.95  31.80  29.89  30.40  1,378,017 
03/05/2025 31.87  31.87  30.05  30.97  1,625,024 
03/04/2025 31.61  32.41  28.01  31.37  1,967,222 
03/03/2025 36.95  36.95  31.47  32.06  2,883,894 
02/28/2025 36.28  37.36  35.14  37.18  766,119 
02/27/2025 37.18  38.23  36.47  36.54  475,089 
02/26/2025 36.82  38.22  36.71  37.18  661,674 
02/25/2025 35.62  36.76  33.93  36.43  946,387 
02/24/2025 36.93  37.23  35.31  35.53  770,994 
02/21/2025 40.11  40.82  36.82  36.91  836,288 
02/20/2025 39.26  40.02  38.70  39.77  467,411 
02/19/2025 38.41  39.76  38.40  39.24  563,519 
02/18/2025 41.50  42.33  39.29  39.39  889,589 
02/14/2025 42.17  42.82  41.22  41.43  481,629 
02/13/2025 42.48  42.71  40.97  41.79  554,424 
02/12/2025 40.79  42.63  40.62  42.12  868,082 
02/11/2025 40.80  44.28  38.89  42.53  2,710,502 
02/10/2025 38.61  39.30  37.84  38.25  722,420 
02/07/2025 38.87  39.44  38.03  38.43  546,102 
02/06/2025 38.99  39.67  38.62  38.88  509,559 
02/05/2025 39.44  40.67  38.81  39.14  729,281 
02/04/2025 37.77  39.56  37.52  39.31  595,257 
02/03/2025 37.46  38.46  36.83  37.71  515,959 
01/31/2025 39.06  39.80  38.20  38.25  575,996 
01/30/2025 38.37  39.60  38.27  39.00  626,620 
01/29/2025 38.27  38.81  37.53  37.73  585,856 
01/28/2025 39.87  39.87  38.25  38.37  948,579 
01/27/2025 38.69  41.00  38.52  39.93  786,498 
01/24/2025 40.47  40.84  39.00  39.33  539,935 
01/23/2025 40.04  41.35  39.02  40.71  918,348 
01/22/2025 39.03  40.75  38.96  40.56  1,087,796 
01/21/2025 38.65  39.36  37.75  39.03  764,137 
01/17/2025 36.91  37.99  36.11  37.59  1,277,260 
01/16/2025 36.06  36.38  35.01  35.85  1,303,304 
01/15/2025 37.07  37.27  35.55  36.19  1,053,342 
01/14/2025 37.44  37.44  34.39  35.57  1,332,705 
01/13/2025 37.21  37.61  34.20  37.48  1,089,666 
01/10/2025 36.98  38.61  35.08  36.72  1,599,904 
01/08/2025 40.01  40.46  38.70  39.17  682,804 
01/07/2025 39.30  40.03  38.45  39.51  987,635 
01/06/2025 38.64  40.10  37.65  38.87  1,383,456 
01/03/2025 37.52  39.31  37.38  38.64  861,239 
01/02/2025 37.77  38.89  36.89  37.28  866,779 
12/31/2024 37.83  38.45  36.07  37.35  1,170,772 
12/30/2024 36.18  36.66  35.25  35.78  791,050 
12/27/2024 36.03  37.27  36.03  36.66  1,214,528 
12/26/2024 35.05  36.89  34.53  36.42  671,602 
12/24/2024 36.13  36.15  35.26  35.75  451,045 

About Biohaven Pharmaceutical Stock history

Biohaven Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biohaven is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biohaven Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biohaven Pharmaceutical stock prices may prove useful in developing a viable investing in Biohaven Pharmaceutical
Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. Biohaven Ltd. is a subsidiary of Biohaven Pharmaceutical Holding Company Ltd. Biohaven is traded on New York Stock Exchange in the United States.

Biohaven Pharmaceutical Stock Technical Analysis

Biohaven Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biohaven Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biohaven Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Biohaven Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Biohaven Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Biohaven Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biohaven to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Biohaven Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biohaven Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biohaven Pharmaceutical Holding Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biohaven Pharmaceutical Holding Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.